Seyedkazemi Setareh
Insider CIK 1903088 · ADVM Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 40,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 42,500 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 48,750 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 43,458 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 25,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 8,500 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | U Tender | 2025-12-09 | 2025-12-10 | 88,332 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | U Tender | 2025-12-09 | 2025-12-10 | 8,125 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2025-12-09 | 2025-12-10 | 85,000 | — | $0 | 88,332 | SEC↗ |
| ADVM Adverum Biotechnologies, I | U Tender | 2025-12-09 | 2025-12-10 | 54,874 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-06-17 | 2025-06-20 | 42,500 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 42,500 | — | $0 | 42,500 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-06-17 | 2025-06-20 | 8,500 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 8,500 | — | $0 | 8,500 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-06-10 | 2025-06-20 | 40,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2025-05-15 | 2025-05-16 | 924 | $2.00 | $1.8K | 13,768 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-02-25 | 2025-02-27 | 48,750 | — | $0 | 48,750 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2025-02-25 | 2025-02-27 | 8,125 | — | $0 | 14,692 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2024-08-02 | 2024-08-06 | 43,458 | — | $0 | 43,458 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2024-02-12 | 2024-02-14 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2023-10-03 | 2024-03-12 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2023-09-15 | 2023-09-18 | 130 | $1.55 | $202 | 47,674 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2023-09-15 | 2023-09-18 | 6,071 | $1.52 | $9.2K | 47,804 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2023-03-01 | 2023-03-03 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | S Sale | 2022-09-19 | 2022-09-21 | 6,058 | $1.07 | $6.5K | 47,875 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2022-09-14 | 2022-09-16 | 33,333 | — | $0 | 53,933 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2022-05-23 | 2022-05-24 | 20,000 | $0.84 | $16.8K | 20,600 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2022-01-06 | 2022-01-10 | 425,000 | — | $0 | 425,000 | SEC↗ |